Novartis shares jump on breast cancer drug trials success
(FOX News Business)

Shares for Novartis are up after the Swiss pharma company reported positive topline results from an interim analysis of NATALEE, a Phase III trial evaluating Kisqali, in a broad population of patients with early breast cancer.